Name: "Anti-CCL2 (X6X1) h(CD28-41BB-CD3_) CAR, pCDCAR1"
Availability: InStock

"Anti-CCL2 (X6X1) h(CD28-41BB-CD3_) CAR, pCDCAR1" | Creative Biolabs

Creative biolabs has developed Lentiviral CAR vector pCDCAR1 CCL2 (X6X1) h(28BB_), which is constructed for the engineering of T cells to target human CCL2. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-CCL2 antibody linked to a CD28 transmembrane domain/ endodomain and CD137 (4-1BB), CD3-zeta signaling domains. And the vector product was designed for the treatment of Colorectal cancer.